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Abstract 
We report two cases of Budd-Chiari syndrome. Case 1: A 57-year-old man presented with 
leg edema and esophageal varices. Cavography showed obstruction of the inferior vena 
cava with antiphospholipid syndrome. Further, the patient showed positive serology for 
hepatitis C virus and consumed large quantities of alcohol. Percutaneous transluminal 
angioplasty was performed on this patient and anticoagulants administered; leg edema 
and esophageal varices were ameliorated although liver biopsy showed cirrhosis without 
evident congestion. More than 9 months since the diagnosis, restenosis of the inferior 
vena cava has not occurred. Case 2: A 73-year-old woman presented abdominal pain but 
no edema or varices. Cavography showed membranous obstruction of the inferior vena 
cava which required no therapy. Manifestation of portal hypertension was not present 
and liver function was maintained although liver biopsy showed obvious congestion. 
These cases showed untypical features against histopathology, and careful observation 
will be required for emergence of hepatocellular carcinoma. 
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Introduction 
Budd-Chiari syndrome (BCS) is a rare disease characterized by the obstruction of 
hepatic venous outflow due to occlusion of the hepatic vein or the inferior vena cava 
(IVC). It leads progressively to sinusoidal congestion, ischemic injury to liver cells, portal 
hypertension and cirrhosis. The etiology of BCS is very diverse; 75% of cases are caused 
by both hereditary and acquired hypercoagulable states, and 25% of cases are idiopathic 
[1]. In Asian countries, most BCS cases are believed to be caused by membranous 
obstruction of the IVC (MOVC), while in Western countries, hepatic vein stenosis caused 
by coagulation disorder or neoplasm is a more common cause of the disease [2]. We 
report two patients with BCS due to IVC obstruction who presented with different 
etiologies, symptoms and untypical histopathologies and clinical courses (table 1). 
Case Reports 
Case 1 
A 57-year-old man was admitted to our hospital because of distended abdomen, fatigue, and leg 
edema. He had a history of acute hepatitis at 18 years of age and bilateral leg thrombophlebitis at 
27 years of age. He denied blood transfusion and a family history of liver disease, but he consumed large 
quantities of alcohol (145 g ethanol/day) and was a heavy smoker (40 cigarettes/day). Physical 
examination revealed a distended abdomen and leg edema with skin eruptions. Laboratory findings 
were as follows: platelet count 21.3 × 10
9/l; albumin 17 g/l; aspartate aminotransferase 35 U/l; alanine 
aminotransferase 12 U/l; alkaline phosphatase 340 U/l; gamma-glutamyltransferase 75 U/l; total 
bilirubin 3.2 mg/dl; prothrombin time 15.7 s (normal 11–14 s); activated thromboplastin time 36.2 s 
(normal 24–38 s); fibrinogen degradation products 28 μg/ml (normal <5 μg/ml); anticardiolipin beta 2-
glycoprotein I (anti-CL/beta 2-GPI) antibody 12.0 U/ml (normal <3.5 U/ml); lupus anticoagulant 1.04 
(normal <1.30); positive hepatitis C virus (HCV) serology (HCV-RNA 1,810 kIU/l; serogroup 2) but not 
hepatitis B virus (HBV). Further, the patient was negative for markers of autoimmune hepatitis, primary 
biliary cirrhosis, Wilson’s disease, and hemochromatosis. 
Esophagogastric duodenoscopy (EGD) showed grade II esophageal varices, while ultrasonic 
cardiogram showed no abnormal findings. Abdominal computed tomography (CT) documented 
obstruction of the IVC, calcification above the obstructive part, extensive subcutaneous collateral veins, 
and dilated azygos and hemiazygos veins. Mild ascites and hepatosplenomegaly were also present. 
Cavography via the femoral vein revealed complete IVC obstruction above the orifice of the middle 
hepatic vein (MHV), and occlusion was not observed in the periphery of the hepatic vein. Further, it 
was observed that the dilated azygous venous system drained into the right atrium (fig. 1a). Since there 
was evident manifestation of portal hypertension and congestion, percutaneous transluminal 
angioplasty (PTA) was successfully performed with complete recanalization of the obstructed IVC 
(fig. 1b). Liver needle biopsy showed pseudolobules surrounded by thick fibrous connective tissue with 
moderate inflammatory infiltrates, indicating liver cirrhosis (fig. 2a). Then administration of heparin 
followed by warfarin was initiated. Six weeks after PTA, the leg edema improved and EGD showed that 
the esophageal varices had reduced to grade I. Restenosis of the IVC has not occurred more than 
9 months since the treatment. 
Case 2 
A 73-year-old woman was admitted to our hospital for further investigation of abdominal pain and 
mild thrombocytopenia. She denied alcohol consumption, blood transfusion, and family history of liver 
disease. Physical examination revealed very mild tenderness at the right hypochondrium and mild 
hepatosplenomegaly but no leg edema. Laboratory studies demonstrated a platelet count of 10.1 × 10
9/l, 
despite normal liver and coagulation function tests. Serology for hepatitis viruses and anticardiolipin 
antibody were all negative. 
EGD and ultrasonic cardiogram showed no abnormal findings. Abdominal CT documented 
obstruction of the IVC, dilated azygos and hemiazygos veins, and extensive subcapsular collateral veins.  
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Mild hepatosplenomegaly, ascites and an enlarged caudate lobe were also observed. Cavography via the 
femoral vein revealed complete obstruction of the IVC immediately under the diaphragm; the hepatic 
vein was not clearly visible although CT delineated the right hepatic vein (RHV) and MHV. 
Additionally, cavography revealed dilated azygos venous system toward the right atrium (fig. 1c). Liver 
needle biopsy showed sinusoidal dilatation with congestion and irregular fibrosis (fig. 2b). Percutaneous 
portal vein (umbilical portion) and MHV pressure measurements were simultaneously performed and 
were 19 and 15 mm Hg, respectively. These findings were consistent with BCS. Since laboratory studies 
presented normal liver and coagulation function tests and manifestation of portal hypertension was not 
evident, PTA was not performed and anticoagulants were not administered. 
Discussion 
BCS is a rare, heterogeneous, and potentially lethal condition related to the obstruction 
of the hepatic venous outflow tract [3]. Various etiologies of BCS are observed. The 
hypercoagulable state (antithrombin III deficiency, protein C/S deficiency, 
factor V Leiden mutation, prothrombin mutation, myeloproliferative disorders, 
paroxysmal nocturnal hemoglobinuria, antiphospholipid syndrome, pregnancy, and 
contraceptive use), tumor invasion, Behçet’s disease, trauma, inflammatory bowel disease, 
and membranous obstruction comprise 75% of cases, and the remaining 25% of cases are 
idiopathic [1]. In Japan, it is generally believed that MOVC in BCS is caused by congenital 
malformation, although Kage et al. clarified that autopsy findings indicate that most cases 
of MOVC were caused by thrombosis [4]. 
In case 1, we diagnosed BCS due to a coagulation disorder since the patient had a 
history of thrombophlebitis 30 years before and exhibited positive serology for the 
anti-CL/beta 2-GPI antibody, indicating the presence of the antiphospholipid syndrome 
which is comparatively uncommon in Asian populations. Cavography showed IVC 
obstruction with a dilated azygos venous system also observed in case 2. However, in 
contrast to the case 2, case 1 had esophageal varices and leg edema. These findings were 
probably caused by HCV infection and consumption of large quantities of alcohol in 
addition to the IVC obstruction. Indeed, liver biopsy showed cirrhosis with moderate 
inflammation in the portal area, indicating viral hepatitis. Mallory body or inflammation 
in the central vein indicating alcoholic liver disease was not observed. Additionally, 
sinusoidal congestion was not evident. 
After successful PTA and anticoagulant administration, the esophageal varices and leg 
edema gradually ameliorated, although liver biopsy suggested cirrhosis. However, PTA 
contains the risk of restenosis that possibly occurs in 17% of cases [5]. Qiao et al. reported 
a long-term effect of stent placement preventing restenosis; they found that restenosis 
after PTA and stent placement occurred in only 9.4% cases [6]. Although the blood flow 
of the IVC has been maintained up to the present time in case 1, second PTA or stent 
placement will be possibly required hereafter. Additionally, long-term administration of 
an anticoagulant will be necessary to prevent restenosis [7, 8]. 
In case 2, a hypercoagulable state and other causes of BCS were not recognized; 
therefore, this case was diagnosed as MOVC. Although the patient presented with the 
classical triad of hepatomegaly, ascites, and abdominal pain, liver dysfunction and 
esophageal varices were not observed. Kamba et al. reported asymptomatic MOVC [9], 
showing complete IVC obstruction and collateral circulation from the RHV to the MHV; 
blood flow from the IVC drained into the right atrium via intrahepatic collaterals between 
the RHV and the MHV. There were no other collateral circulations such as the intercostal 
and the azygos venous systems, and the authors assessed that the intrahepatic shunt 
prevented the development of other collaterals and the emergence of various symptoms.  
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The patient showed MOVC with extended subcapsular veins and a markedly dilated 
azygos venous system toward the right atrium but no intrahepatic shunt. Further, liver 
biopsy showed sinusoidal dilatation with congestion and irregular fibrosis indicating 
typical BCS. Therefore, various manifestations such as leg edema, esophageal varices, and 
liver dysfunction will be evident in the future. We speculate that low platelet count was 
due to hypersplenism, although maintained liver function was uncommon. Murad et al. 
reported that encephalopathy, ascites, prothrombin time, and bilirubin were independent 
determinants of survival rates, and overall survival rates at 1, 5 and 10 years were 82, 69 
and 62%, respectively [10]. The patient had ascites, so careful follow-up will be required. 
It is important to note that the incidence of hepatocellular carcinoma in BCS patients 
is definitely high. Matsui et al. reported that the incidence was 25% and chronic liver 
congestion may contribute to hepatocarcinogenesis in MOVC [11]. Moreover, Okuda et 
al. emphasized the importance of the difference between primary hepatic vein thrombosis 
and obliterative disease predominantly affecting the hepatic portion of the IVC; the latter 
is frequently complicated by hepatocellular carcinoma, the former is not [12]. Therefore, 
the IVC obstruction could be a major predictor for hepatocellular carcinoma 
development. Our two cases showed obstruction of the IVC, and case 1 was serologically 
positive for HCV. Likewise, careful observation will be required. 
In conclusion, we have described two cases of BCS. In one case obstruction of the IVC 
caused by a coagulation disorder was observed along with various manifestations that 
were ameliorated by PTA and anticoagulant administration although liver biopsy 
indicated cirrhosis; in the other case, MOVC with maintained liver function was observed 
and therapy was not required although liver biopsy indicated typical BCS. 
 
 
 
Table 1. Comparison of the two cases 
  Case 1  Case 2 
Sex male  female 
Age  57 years  73 years 
Varices, leg edema  (+)  (–) 
Alcohol consumption  (+)  (–) 
Hepatitis virus  HCV(+)  (–) 
Liver dysfunction  (+)  (–) 
Etiology antiphospholipid  syndrome  MOVC 
Obstructive part  IVC  IVC 
Histopathology  pseudolobule with  
inflammation 
sinusoidal dilatation with 
congestion 
Therapy PTA,  anticoagulants  (–) 
HCV = Hepatitis C virus; MOVC = membranous obstruction of the inferior vena cava; 
IVC = inferior vena cava; PTA = percutaneous transluminal angioplasty. 
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Fig. 1. a Cavography via the femoral vein. Complete obstruction of the IVC with the dilated azygos 
venous system drained into the right atrium. b Cavography via the femoral vein and internal jugular 
vein. PTA via the internal jugular vein and femoral vein recanalized the IVC. c Cavography via the 
femoral vein. The markedly dilated azygos venous system drained into the right atrium. 
 
 
 
Fig. 2. a Liver biopsy. The section showed pseudolobules surrounded by thick fibrous connective tissue 
with moderate inflammatory cell infiltration. b Liver biopsy. The section showed sinusoidal dilatation 
with congestion and irregular fibrosis. 
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